rhigm22: a novel investigational compound to enhance remyelination in the cns
Published 10 years ago • 1.4K plays • Length 33:33Download video MP4
Download video MP3
Similar videos
-
18:20
bench to bedside: myelination 1 - myelination, remyelination and multiple sclerosis - mikael simons
-
2:15
role of oligodendrocytes in demyelination & remyelination in ms: future research
-
9:40
#remyelination in #ms
-
2:53
multiple sclerosis remyelination trial update: metformin and clemastine
-
8:02
lipid-dependent processes within cns demyelination and remyelination
-
36:28
remyelination in multiple sclerosis
-
2:27
demyelination disorder | dr. kranthi mohan
-
5:50
remyelination in multiple sclerosis
-
15:41
abraham cisneros-mejorado - demyelination in a murine model of ms monitored with dmri and histology
-
0:57
cns inflammation in ms: a novel target in progressive disease
-
1:43
stimulating remyelination in ms models
-
58:42
“remyelination in multiple sclerosis” by dr. jenny feng
-
1:12
imaging highlights in ms: updated guidelines, novel markers & remyelination
-
14:06
remyelination in multiple sclerosis: novoron bioscience
-
4:23
anti-lingo-1 and remyelination
-
6:35
neddylation as a novel therapeutic target in multiple sclerosis
-
1:59
demyelinating disorders: impact of a novel biomarker on clinical practice
-
16:10
remyelination research in multiple sclerosis
-
31:24
stimulating remyelination: an unexpected research journey
-
11:32
ms mri lesions vs. "benign" white matter lesions explained by neurologist
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
4:50
biology or poor trial design…what underlies remyelination trial failures in ms?